Physician profile

Amy L Illescas

Internal Medicine · Hoover, AL

NPI 1346269123

$19,952.10

in general payments reported to CMS, 2019-2025

80 companies · $2,964 in 2025

The $2,964 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$9,529.33

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $3,943.92 2019-2025 Ozempic, Rybelsus, Wegovy
Lilly USA, LLC $1,972.89 2019-2025 Mounjaro, Jardiance, Zepbound
Abbvie INC. $1,832.84 2020-2025
Pfizer INC. $1,142.00 2019-2025
Dexcom, INC. $1,065.99 2021-2025 Dexcom G6 Transmitter
Amgen INC. $1,039.06 2019-2025 Otezla, Repatha, Otezla
Bayer Healthcare Pharmaceuticals INC. $901.30 2021-2025
Takeda Pharmaceuticals U.S.A., INC. $759.54 2019-2025 Trintellix
Allergan, INC. $589.80 2019-2020
Astrazeneca Pharmaceuticals LP $584.80 2019-2024 Farxiga, Airsupra
Exact Sciences Corporation $411.14 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $400.46 2019-2025 Xifaxan
Antares Pharma, INC. $382.73 2019-2025 Xyosted, Tlando, Nocdurna
Intra-Sana Laboratories $276.59 2024-2025 Reltone 200 Mg, Reltone 400 Mg, Glycate
Merck Sharp & Dohme LLC $275.64 2019-2022
Show all 80 companies
CompanyGeneral paymentsYearsTop products
Ironwood Pharmaceuticals, INC $255.99 2020-2024 Linzess
Boehringer Ingelheim Pharmaceuticals, INC. $253.05 2019-2025 Jardiance
Biohaven Pharmaceutical Holding Company LTD. $247.40 2022
Otsuka America Pharmaceutical, INC. $192.60 2022-2025 Rexulti
Vivus LLC $191.17 2019-2022
Upsher-Smith Laboratories LLC $186.91 2020-2023
Neos Therapeutics, LP $182.06 2019-2024 Adzenys Xr-Odt
Janssen Pharmaceuticals, INC $172.01 2019-2023 Xarelto
Astellas Pharma US INC $150.86 2023-2025 Veozah, Myrbetriq
Phathom Pharmaceuticals, INC. $147.73 2024-2025 Voquezna
Amarin Pharma, INC. $144.92 2019-2021
Ardelyx, INC. $139.83 2024-2025 Ibsrela
Lundbeck LLC $122.88 2020-2021
Xeris Pharmaceuticals, INC. $98.57 2022-2025 Gvoke Hypopen, Recorlev
Shield Therapeutics INC $97.02 2022-2025 Accrufer
Halozyme INC $93.66 2023
Glaxosmithkline, LLC. $91.58 2021-2024 Trelegy Ellipta
Esperion Therapeutics, INC. $90.11 2020-2022
Abbott Laboratories $83.23 2019-2024 Freestyle Libre
Corium, LLC $69.23 2023 Azstarys
Hologic Sales and Service, LLC $69.14 2021-2024 Aptima
Supernus Pharmaceuticals, INC. $65.27 2019-2023 Tlando, Xyosted, Qelbree
Genentech USA, INC. $63.37 2019-2021
Idorsia Pharmaceuticals US INC $63.11 2022-2024 Quviviq
Nabriva Therapeutics, Plc $62.58 2020-2022
Biohaven Pharmaceuticals, INC. $57.52 2020-2021
Almatica Pharma LLC $56.69 2023-2024 Loreev Xr, Gralise
Eisai INC. $56.52 2019-2021
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $49.50 2024-2025 Caplyta
Beta Bionics, INC. $45.91 2024-2025 Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach
Sanofi-Aventis U.S. LLC $41.00 2022-2025
Tolmar, INC. $40.60 2023-2025 Jatenzo
Verity Pharmaceuticals INC. $38.61 2024-2025 Tlando
Neurocrine Biosciences, INC. $37.95 2022
Nalpropion Pharmaceuticals LLC $35.62 2019
Ibsa Pharma INC. $33.96 2020-2025 Flector, Licart, Tirosint
Collegium Pharmaceutical, INC. $29.86 2022-2025 Jornay Pm
Axsome Therapeutics, INC. $29.53 2023 Auvelity
Currax Pharmaceuticals LLC $28.54 2023-2025 Contrave, Onzetra Xsail, Nexletol
Assertio Therapeutics, INC. $27.42 2020
Boston Scientific Corporation $27.17 2024
Regeneron Healthcare Solutions, INC. $24.30 2023 Evkeeza
Mannkind Corporation $23.98 2019
Jazz Pharmaceuticals INC. $23.93 2021-2022
Arbor Pharmaceuticals, INC. $23.15 2020
Alexion Pharmaceuticals, INC. $21.33 2023 Strensiq
Inari Medical, INC. $21.13 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Siemens Medical Solutions USA, INC. $21.00 2025 Immulite 1000 Immunoassay System
Noven Therapeutics, LLC $19.78 2024 Xelstrym
Corcept Therapeutics $18.65 2023 Korlym
Novartis Pharmaceuticals Corporation $18.59 2023
Tandem Diabetes Care, INC. $17.76 2024 T:Slim X2 Insulin Pump With Control-Iq
Daiichi Sankyo INC. $15.25 2019
Shire North American Group INC $14.44 2019
Medtronic, INC. $14.26 2022
Ironshore Pharmaceuticals INC. $14.26 2024
Optinose US, INC. $14.22 2024
Redhill Biopharma INC. $13.72 2021
Viiv Healthcare Company $13.11 2022
Tris Pharma INC $12.80 2022
Amneal Pharmaceuticals LLC $12.45 2021
Kowa Pharmaceuticals America, INC. $11.70 2019
Teva Pharmaceuticals USA, INC. $11.16 2020
Avion Pharmaceuticals $10.96 2019
Aytu Biopharma, INC. $10.79 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amy L Illescas

$19,952.10

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $2,964 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/197245/amy-l-illescas

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.